Published in Br Med J on November 04, 1972
The extrarenal correction of alkalosis associated with potassium deficiency. J Clin Invest (1952) 5.08
Implementing clinical guidelines. It works in Australia. BMJ (1993) 2.25
Improving the quality of antibiotic prescription patterns in general practice. The role of educational intervention. Med J Aust (1994) 2.02
Changing antibiotic prescribing by educational marketing. Med J Aust (1989) 1.70
Covert self poisoning with brodifacoum, a 'superwarfarin'. Aust N Z J Med (1990) 1.42
Lidocaine in the prevention of sudden death in the pre-hospital phase of acute infarction. A double-blind study. N Engl J Med (1974) 1.29
Impact of a toxicology service on a metropolitan teaching hospital. Emerg Med (Fremantle) (2001) 1.27
A decade of antibiotic use in a teaching hospital. Med J Aust (1989) 1.21
Double-blind, placebo controlled, crossover study of lamotrigine in treatment resistant partial seizures. J Neurol Neurosurg Psychiatry (1993) 1.08
The effect of food ingestion on circulating neurotensin-like immunoreactivity (NTLI) in the human. Acta Physiol Scand (1978) 1.04
MRI measurement of wall shear stress vectors in bifurcation models and comparison with CFD predictions. J Magn Reson Imaging (2001) 0.99
Prolonged effects of chronic guanethidine treatment on the sympathetic innervation of the genitalia of male rats. Med J Aust (1971) 0.98
Interactions between local anesthetics and spasmogens on the guinea-pig ileum. J Pharmacol Exp Ther (1976) 0.94
A pharmacological investigation of synthetic substance P on the isolated guinea-pig ileum. Clin Exp Pharmacol Physiol (1977) 0.93
Effects of cimetidine and ranitidine on hepatic drug metabolism. Clin Pharmacol Ther (1982) 0.93
Biological activity of C-terminal partial sequences of substance P. J Med Chem (1976) 0.93
Use of a drug-screening service in an inner-city teaching hospital. Med J Aust (1981) 0.92
Hepatic extraction of morphine is impaired in cirrhosis. Eur J Clin Pharmacol (1989) 0.92
Paracetamol self-poisoning: diagnosis, management, and outcome. Med J Aust (1982) 0.91
Decreased oral warfarin clearance after ranitidine and cimetidine. Clin Pharmacol Ther (1984) 0.87
Electronic antibiotic stewardship--reduced consumption of broad-spectrum antibiotics using a computerized antimicrobial approval system in a hospital setting. J Antimicrob Chemother (2008) 0.87
UDP glucuronosyltransferase in the cirrhotic rat liver. J Gastroenterol Hepatol (1996) 0.86
Liquid chromatographic assay for debrisoquine and 4-hydroxydebrisoquine in urine. J Chromatogr (1986) 0.86
Incidence of antibiotic-related diarrhoea and pseudomembranous colitis: a prospective study of lincomycin, clindamycin and ampicillin. Med J Aust (1977) 0.86
Elimination of amphotericin B in impaired renal function. Clin Pharmacol Ther (1983) 0.86
Blood bradykinin levels in the human. Aust J Exp Biol Med Sci (1967) 0.85
Determination of blood kinin levels by radioimmunoassay. Biochem Pharmacol (1972) 0.85
Analysis of trimethoprim and sulphamethoxazole in human plasma by high-pressure liquid chromatography. J Chromatogr (1979) 0.85
The effect of hormones on the expression of five isoforms of UDP-glucuronosyltransferase in primary cultures of rat hepatocytes. Pharm Res (1999) 0.85
Sex hormones differentially regulate isoforms of UDP-glucuronosyltransferase. Pharm Res (1997) 0.84
Prolonged hypotension and ultrastructural changes in sympathetic neurones following guanacline treatment. Eur J Pharmacol (1971) 0.84
Non-equilibrium behavior of sticky colloidal particles: beads, clusters and gels. Eur Phys J E Soft Matter (2005) 0.84
Bilirubin and bile acids may modulate their own metabolism via regulating uridine diphosphate-glucuronosyltransferase expression in the rat. J Gastroenterol Hepatol (2000) 0.83
Regulation of uridine diphosphate glucuronosyltransferase during the acute-phase response. J Gastroenterol Hepatol (1998) 0.83
A [14C]phenacetin breath test to measure hepatic function in man. Hepatology (1984) 0.83
Possible physiological and pathological roles of the kallikrein-kinin system. Med J Aust (1972) 0.82
Assay of flucytosine (5-fluorocytosine) in human plasma by high-pressure liquid chromatography. Antimicrob Agents Chemother (1979) 0.82
Release of neurotensin-like immunoreactivity (NTLI) from the gut in anaesthetized dogs. Acta Physiol Scand (1978) 0.82
Absorption of orally administered amphotericin B lozenges. Br J Clin Pharmacol (1983) 0.82
Surveying antibiotic use in a general teaching hospital. Med J Aust (1979) 0.81
The effects of metoclopramide in modifying the response of isolated guinea-pig ileum to various agonists. J Pharmacol Exp Ther (1976) 0.79
THE PRESSOR EFFECT OF TYRAMINE IN MAN AND ITS MODIFICATION BY RESERPINE PRETREATMENT. J Clin Invest (1963) 0.79
The Australian method of drug-event assessment. Special workshop--regulatory. Drug Inf J (1984) 0.79
The effects of age and chronic liver disease on the elimination of temazepam. Eur J Clin Pharmacol (1986) 0.79
Alcohol up-regulates UDP-glucuronosyltransferase mRNA expression in rat liver and in primary rat hepatocyte culture. Life Sci (2000) 0.79
Substance P: its pharmacology and physiological roles. Aust J Exp Biol Med Sci (1977) 0.79
Use of prophylactic antibiotics in surgery. Med J Aust (1980) 0.78
Modified trimethoprim-sulphamethoxazole doses in Pneumocystis carinii pneumonia. Lancet (1987) 0.78
Cimetidine impairs the elimination of chlormethiazole. Eur J Clin Pharmacol (1981) 0.77
Perhexiline maleate in the treatment of severe angina pectoris. Med J Aust (1979) 0.77
Cardiac arrest after intravenous injection of cimetidine. Med J Aust (1980) 0.76
The effect of ethanol administration on the disposition and elimination of chlormethiazole. Eur J Clin Pharmacol (1983) 0.76
Acute phenylbutazone poisoning in a child. Med J Aust (1983) 0.75
Clonidine in the treatment of hypertension. Br Med J (1971) 0.75
Neutralization by an antibody of some vascular actions of bradykinin. Biochem Pharmacol (1971) 0.75
Use of single doses and rapid sampling to detect interactions with cimetidine. Eur J Clin Pharmacol (1984) 0.75
Felodipine compared to prazosin as additional therapy to a beta-blocking drug. J Cardiovasc Pharmacol (1987) 0.75
Rational therapeutics: the way ahead. Med J Aust (1992) 0.75
Assessment of general practitioners' management of hyperlipidaemia. A study using personal visits and a scenario-based questionnaire. Aust Fam Physician (1994) 0.75
Effect of adrenaline on blood kinin levels in carcinoid syndrome and in normal subjects. Australas Ann Med (1967) 0.75
Anorectic drugs. A cause of pulmonary hypertension? Med J Aust (1984) 0.75
Nuclear war and anxiety. Aust Fam Physician (1988) 0.75
Overdose--a problem that is still with us. Med J Aust (1986) 0.75
Determination of human urinary kinin levels by radioimmunoassay using a tyrosine analogue of bradykinin. Biochem Pharmacol (1971) 0.75
Determination of carbamazepine in plasma. J Chromatogr (1974) 0.75
Release of latent glucuronosyltransferase activity contributes to the sparing of glucuronidation in experimental liver injuries. J Gastroenterol Hepatol (1994) 0.75
Sex differences in level of a vasoactive plasma protein and changes during pregnancy. Experientia (1970) 0.75
The role of bradykinin in endotoxic shock of intestinal origin. Aust N Z J Surg (1977) 0.75
Spermatic granuloma of the epididymis in rats treated with guanethidine. J Pathol (1974) 0.75
Cause of flushing in carcinoid syndrome. Lancet (1971) 0.75
Disposition of intravenous glycofurol: effect of hepatic cirrhosis. Clin Pharmacol Ther (1984) 0.75
The unsuitability of minoxidil for the treatment of moderate hypertension. Med J Aust (1986) 0.75
Adverse drug reactions. Important issues. Aust Fam Physician (1987) 0.75
Hepatic enzyme activity is the major factor determining elimination rate of high-clearance drugs in cirrhosis. Hepatology (1993) 0.75
The action of adrenal steroids on the pharmacological reactivity of the isolated vein of the rabbit ear. Naunyn Schmiedebergs Arch Exp Pathol Pharmakol (1969) 0.75
Studies on the mechanisms of action of activated charcoal on theophylline pharmacokinetics. J Pharm Pharmacol (1987) 0.75
UDP-glucuronosyltransferase in the regenerating rat liver. J Gastroenterol Hepatol (1996) 0.75
Appetite suppressant drugs. Med J Aust (1986) 0.75
Adaptive bolus-based set-point regulation of hyperglycemia in critical care. Conf Proc IEEE Eng Med Biol Soc (2004) 0.75
Factors affecting the hepatic elimination of oxidized and of glucoronidated high clearance drugs following acute administration of carbon tetrachloride. J Hepatol (1994) 0.75
Teaching practical classes in clinical pharmacology. Med J Aust (1971) 0.75
Letter: Hyperactivity after a sulphonamide. Lancet (1974) 0.75
A vasodepressor peptide in Cohn fraction III-O of human plasma proteins. Adv Exp Med Biol (1976) 0.75
Physiological changes in blood bradykinin levels in man. Aust J Exp Biol Med Sci (1967) 0.75
Intensive monitoring of drug use in a hospital. Med J Aust (1972) 0.75
A double-blind trial of lidocaine in acute myocardial infarction. Med J Aust (1973) 0.75
Bradykinin antagonism by dimethothiazine. J Pharm Pharmacol (1969) 0.75
A perfused vein preparation sensitive to plasma kinins. Naunyn Schmiedebergs Arch Exp Pathol Pharmakol (1969) 0.75
A double-blind trial of perhexiline maleate in the prophylaxis of angina pectoris. Med J Aust (1976) 0.75
Pharmacotherapeutics: what a difference five decades makes! Med J Aust (2001) 0.75
Arterial lignocaine concentrations following cervical plexus blockade for carotid endarterectomy. Anaesth Intensive Care (1991) 0.75
The effect of an antacid and food on the absorption of cimetidine and ranitidine. J Pharm Pharmacol (1990) 0.75
Adverse effects of anticoagulants. Adverse Drug React Acute Poisoning Rev (1990) 0.75
The effect of a nutritional model of chronic liver injury on the hepatic glucuronidation of morphine in rats. J Pharm Pharmacol (1993) 0.75
Mianserin. An example of balancing benefits and risks in therapy. Med J Aust (1984) 0.75